Sarilumab (interleukin-6 receptor monoclonal antibody) for the treatment of pemphigus vulgaris

Clin Exp Dermatol. 2023 Aug 25;48(9):1055-1056. doi: 10.1093/ced/llad173.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal* / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Humans
  • Pemphigus* / drug therapy
  • Receptors, Interleukin-6
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • sarilumab
  • Antibodies, Monoclonal, Humanized
  • Receptors, Interleukin-6